In an extraordinary leap forward for biosensing technology, researchers have developed a groundbreaking stretchable electrochemical sensor designed to operate within the dynamic and challenging environment of the gut. This innovative platform overcomes longstanding hurdles in real-time monitoring of neurotransmitters, notably serotonin (5-hydroxytryptamine or 5-HT), within the complex intestinal milieu—marking a pivotal advancement in the integration of immune, mechanical, and chemical signaling pathways in vivo.
The gastrointestinal tract is a sophisticated organ system whose functionality extends far beyond digestion and nutrient absorption. It serves as a critical interface where the immune and nervous systems mutually interact, responding to food-derived and microbial stimuli alongside mechanical forces generated by peristalsis. Decoding how these multifaceted signals are integrated to coordinate physiological responses has challenged scientists for decades, primarily due to technical limitations in detecting neurotransmitters under such mechanically and chemically complex conditions.
The new sensor platform introduces a meticulously engineered one-dimensional nanoconductive network embedded within a flexible polydimethylsiloxane (PDMS) substrate. Central to the design is an unordered gold nanotube (Au NT) mesh that forms interlocking conductive pathways capable of accommodating extensive mechanical deformation without loss of electrical continuity. Unlike conventional electrodes prone to failure or signal distortion when subjected to rhythmic intestinal contractions, this innovative structure enables stable electrochemical outputs even under stretching, bending, and expansion — critical for accurate biosensing in vivo.
Complementing the robust conductive framework is a smart interface comprised of poly(3,4-ethylenedioxythiophene) (PEDOT) functionalized with 2-hydroxypropyl-β-cyclodextrin (HC). This engineered coating harnesses host-guest chemistry, allowing the sensor to selectively recognize and bind serotonin molecules amid a milieu teeming with chemically similar neurotransmitters like dopamine and epinephrine. The cyclodextrin’s hydrophobic cavity acts as a molecular trap, achieving remarkable discrimination in molecular recognition, while the hydrophilic outer shell effectively resists protein adsorption and fouling—ensuring sensor durability for prolonged periods in biological environments.
Performance evaluations reveal unparalleled sensitivity and specificity: with a detection limit as low as 3.9 nanomolar and a linear dynamic range spanning physiologically relevant serotonin concentrations (10 to 20 micromolar), the sensor facilitates precise tracking of neurotransmitter fluctuations at both cellular and tissue scales. The anti-biofouling properties maintain signal stability for up to 72 hours in complex biological matrices, overcoming one of the most significant barriers limiting long-term implantable sensors.
The utility of this novel platform was demonstrated through integrative experiments coupling an in situ electrochemical sensing system with ex vivo tissue cultures and isolated intestinal cells. These studies elucidated the pivotal role of enterochromaffin cells (ECs), specialized epithelial cells responsible for serotonin synthesis and secretion within the gut lining. Remarkably, the sensor revealed how various microbe-associated molecular patterns—including viral mimic poly(I:C), bacterial lipopolysaccharide (LPS), and fungal zymosan—augment the mechanosensitivity of ECs and potentiate serotonin release in response to mechanical stimulation.
Mechanistic investigations uncovered that these microbial signals activate pattern-recognition receptors on ECs, triggering intracellular signaling cascades through the p38 mitogen-activated protein kinase (MAPK) pathway. This activation induces dual regulation: upregulation of Piezo2, a mechanosensitive ion channel linked to enhanced mechanical detection and secretion, alongside increased expression of tryptophan hydroxylase 1 (TPH1), the rate-limiting enzyme in serotonin biosynthesis. Consequently, these molecular adaptations enhance both the storage and mechanical responsiveness of serotonin release.
At the tissue level, microbe-driven stimulation was also found to elevate the density of enterochromaffin cells, indicating a broader adaptive remodeling of the intestinal sensory landscape. These insights position ECs as complex integrators of chemical, mechanical, and immune information, functioning in vivo not only as effectors but as key sensors amplifying intestinal signaling under both physiological and pathological states.
Crucially, the findings shed light on how ECs recalibrate their threshold for activation during infection or inflammation by increasing neurotransmitter production and sensitivity to mechanical cues simultaneously. This dual adaptation may explain the heightened gut sensitivity and altered motility characteristic of disorders such as irritable bowel syndrome (IBS) and chronic constipation, conditions frequently linked to dysregulated serotonin signaling.
In overcoming three formidable technical challenges—mechanical deformation, biofouling, and cross-molecular interference—the Au@HCP nanotube sensor represents a monumental step toward reliable, real-time electrochemical biosensing inside living organisms. Its design principles and materials innovations are broadly applicable, promising to catalyze new research into complex organic interfaces within other bodily systems that similarly endure mechanical stresses and biochemical complexities.
This sensor’s success exemplifies the powerful synergy of nanotechnology, materials science, and electrochemistry in resolving multifactorial biomedical problems. By enabling unprecedented access to the dynamics of intestinal neurotransmitter release and immune-mechanical crosstalk, the platform opens a new frontier in gastrointestinal biology and disease diagnostics, with profound implications for personalized medicine and therapeutic interventions targeting gut-brain interactions.
The ability to monitor neurotransmitters such as serotonin in vivo with high precision and stability ushers a new era of organ-level sensing, facilitating not only basic scientific understanding but also clinical translation. Future developments are likely to extend this approach into other critical neurotransmitters and bioactive molecules, transforming how clinicians detect and manage complex gastrointestinal disorders linked to neural and immune dysregulation.
The elegantly engineered Au@HCP nanostructure stands as a beacon of next-generation biosensor technology—combining multifunctionality, durability, and selectivity in a single platform finely tuned for the dynamic and multifarious intestinal ecosystem. As research delves deeper into the orchestra of signals conveyed by enterochromaffin cells, this sensor will be a crucial tool in unraveling the molecular dialogues that govern gut health and disease, ultimately contributing to innovations in diagnostic precision and therapeutic efficacy.
—
Subject of Research: Electrochemical biosensing of intestinal serotonin dynamics and immune-mechanical integration.
Article Title: Not explicitly provided in the source content.
News Publication Date: Not explicitly provided in the source content.
Web References: http://dx.doi.org/10.1016/j.scib.2026.03.060
References: Not explicitly provided in the source content.
Image Credits: ©Science China Press
Keywords
Stretchable electrochemical sensor, serotonin monitoring, enterochromaffin cells, intestinal mechanosensation, host-guest chemistry, nanoconductive network, biofouling resistance, gut-brain axis, p38 MAPK pathway, Piezo2, tryptophan hydroxylase 1, irritable bowel syndrome.
